These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12502989)

  • 21. Early and late reversibility of rocuronium bromide.
    van den Broek L; Proost JH; Wierda JM
    Eur J Anaesthesiol Suppl; 1994; 9():128-32. PubMed ID: 7925203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin.
    Spacek A; Nickl S; Neiger FX; Nigrovic V; Ullrich OW; Weindmayr-Goettel M; Schwall B; Taeger K; Kress HG
    Anesthesiology; 1999 Jun; 90(6):1551-5. PubMed ID: 10360851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.
    Cooper RA; Maddineni VR; Mirakhur RK; Wierda JM; Brady M; Fitzpatrick KT
    Br J Anaesth; 1993 Aug; 71(2):222-6. PubMed ID: 8123396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. A clinical and pharmacokinetic study.
    Servin FS; Lavaut E; Kleef U; Desmonts JM
    Anesthesiology; 1996 May; 84(5):1092-100. PubMed ID: 8624003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Randomized, multicenter study of interaction between Org 9426 (rocuronium bromide) and anesthetic agents in Japanese population].
    Kotake Y; Takeda J; Ozaki M; Saeki S; Otagiri T; Kiyama S; Uchimoto R; Iwao Y
    Masui; 2006 Jul; 55(7):873-9. PubMed ID: 16856548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure.
    Robertson EN; Driessen JJ; Booij LH
    Eur J Anaesthesiol; 2005 Jan; 22(1):4-10. PubMed ID: 15816565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hemodynamic effects of ephedrine on the onset time of rocuronium in pigs.
    Herweling A; Latorre F; Herwig A; Horstick G; Kempski O; Gervais HW
    Anesth Analg; 2004 Dec; 99(6):1703-1707. PubMed ID: 15562058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of rocuronium on the level and mode of pre-synaptic acetylcholine release by facial and somatic nerves, and changes following facial nerve injury in rabbits.
    Tan J; Xu J; Xing Y; Chen L; Li S
    Int J Clin Exp Pathol; 2015; 8(2):1479-90. PubMed ID: 25973033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
    Cordero Escobar I
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs.
    Pedersen K; Kruhøffer LL; Lykkesfeldt J; Kousholt BS
    Acta Vet Scand; 2022 Dec; 64(1):38. PubMed ID: 36522634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.
    Sparr HJ; Wierda JM; Proost JH; Keller C; Khuenl-Brady KS
    Br J Anaesth; 1997 Mar; 78(3):267-73. PubMed ID: 9135303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rocuronium in two myasthenic patients undergoing thymectomy.
    Sanfilippo M; Fierro G; Cavalletti MV; Biancari F; Vilardi V
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1365-6. PubMed ID: 9422307
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of rocuronium (ORG 9426) in patients with chronic renal failure.
    Khuenl-Brady KS; Pomaroli A; Pühringer F; Mitterschiffthaler G; Koller J
    Anaesthesia; 1993 Oct; 48(10):873-5. PubMed ID: 8238829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine potentiation of neuromuscular blocking agents in guinea-pigs.
    Nitahara K; Kornak P; Nagashima H; Vizi ES; Foldes FF; Dan K
    Br J Anaesth; 2000 Feb; 84(2):245-7. PubMed ID: 10743461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of rocuronium bromide in obese female patients.
    Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
    Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to rocuronium of rat diaphragm as compared with limb muscles.
    Huang L; Yang M; Chen L; Li S
    J Surg Res; 2014 Dec; 192(2):471-9. PubMed ID: 25112806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precurarization and priming: a theoretical analysis of safety and timing.
    Kopman AF; Khan NA; Neuman GG
    Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.